U.S. flag

An official website of the United States government

NM_000546.6(TP53):c.373A>C (p.Thr125Pro) AND Li-Fraumeni syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 25, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001041773.9

Allele description [Variation Report for NM_000546.6(TP53):c.373A>C (p.Thr125Pro)]

NM_000546.6(TP53):c.373A>C (p.Thr125Pro)

Gene:
TP53:tumor protein p53 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000546.6(TP53):c.373A>C (p.Thr125Pro)
HGVS:
  • NC_000017.11:g.7675996T>G
  • NG_017013.2:g.16555A>C
  • NM_000546.4:c.373A>C
  • NM_000546.6:c.373A>CMANE SELECT
  • NM_001126112.3:c.373A>C
  • NM_001126113.3:c.373A>C
  • NM_001126114.3:c.373A>C
  • NM_001126118.2:c.256A>C
  • NM_001276695.3:c.256A>C
  • NM_001276696.3:c.256A>C
  • NM_001276760.3:c.256A>C
  • NM_001276761.3:c.256A>C
  • NP_000537.3:p.Thr125Pro
  • NP_000537.3:p.Thr125Pro
  • NP_001119584.1:p.Thr125Pro
  • NP_001119585.1:p.Thr125Pro
  • NP_001119586.1:p.Thr125Pro
  • NP_001119590.1:p.Thr86Pro
  • NP_001263624.1:p.Thr86Pro
  • NP_001263625.1:p.Thr86Pro
  • NP_001263689.1:p.Thr86Pro
  • NP_001263690.1:p.Thr86Pro
  • LRG_321t1:c.373A>C
  • LRG_321:g.16555A>C
  • LRG_321p1:p.Thr125Pro
  • NC_000017.10:g.7579314T>G
  • NM_000546.5:c.373A>C
  • NM_000546.6:c.373A>C
Protein change:
T125P
Links:
dbSNP: rs1057520003
NCBI 1000 Genomes Browser:
rs1057520003
Molecular consequence:
  • NM_000546.6:c.373A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126112.3:c.373A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126113.3:c.373A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126114.3:c.373A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126118.2:c.256A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276695.3:c.256A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276696.3:c.256A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276760.3:c.256A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276761.3:c.256A>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Li-Fraumeni syndrome (LFS)
Synonyms:
Sarcoma family syndrome of Li and Fraumeni
Identifiers:
MONDO: MONDO:0018875; MedGen: C0085390; OMIM: PS151623

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001205410Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Sep 25, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.

Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamaru R, Ishioka C.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8424-9. Epub 2003 Jun 25.

PubMed [citation]
PMID:
12826609
PMCID:
PMC166245

Germline TP53 variants and susceptibility to osteosarcoma.

Mirabello L, Yeager M, Mai PL, Gastier-Foster JM, Gorlick R, Khanna C, Patiño-Garcia A, Sierrasesúmaga L, Lecanda F, Andrulis IL, Wunder JS, Gokgoz N, Barkauskas DA, Zhang X, Vogt A, Jones K, Boland JF, Chanock SJ, Savage SA.

J Natl Cancer Inst. 2015 Apr 20;107(7). doi:pii: djv101. 10.1093/jnci/djv101. Print 2015 Jul.

PubMed [citation]
PMID:
25896519
PMCID:
PMC4651039
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001205410.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

Experimental studies have shown that this missense change affects TP53 function (PMID: 12826609). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 376666). This missense change has been observed in individual(s) with medulloblastoma and/or osteosarcoma (PMID: 25896519, 29753700; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces threonine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 125 of the TP53 protein (p.Thr125Pro).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024